Laurion Capital Management
360 Madison Avenue, Suite 1900, New York, NY, 10017, United States
Overview
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
Enerside | Sep 2025Participated | $9 MOther Equity | |
Aardvark Therapeutics | May 2024Participated | $85 MSeries C | |
COMPASS Pathways | Aug 2023Participated | $285 MOther Equity | |
MerQube | Jul 2023Participated | $22 MSeries B | |
Axoni | Apr 2023Participated | $20 MOther Equity | |
Opensee | Dec 2022Participated | $12 MSeries A | |
RayzeBio | Sep 2022Participated | $160 MSeries D | |
TRex Bio | Mar 2022Participated | $26 MSeries A | |
Scipher Medicine | Feb 2022Participated | $110 MOther Equity | |
Ambys Medicines | Dec 2021Participated | $47 MSeries A | |
AnHeart Therapeutics | Dec 2021Participated | $61 MSeries B | |
LEXEO Therapeutics | Sep 2021Participated | $100 MSeries B | |
Enerside | Sep 2025Participated | $9 MOther Equity | |
Aardvark Therapeutics | May 2024Participated | $85 MSeries C | |
COMPASS Pathways | Aug 2023Participated | $285 MOther Equity | |
MerQube | Jul 2023Participated | $22 MSeries B | |
Axoni | Apr 2023Participated | $20 MOther Equity | |
Opensee | Dec 2022Participated | $12 MSeries A | |
RayzeBio | Sep 2022Participated | $160 MSeries D | |
TRex Bio | Mar 2022Participated | $26 MSeries A | |
Scipher Medicine | Feb 2022Participated | $110 MOther Equity | |
Ambys Medicines | Dec 2021Participated | $47 MSeries A | |
AnHeart Therapeutics | Dec 2021Participated | $61 MSeries B | |
LEXEO Therapeutics | Sep 2021Participated | $100 MSeries B |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Series A | 0 | 3 |
| Series B | 0 | 5 |
| Series C+ | 0 | 5 |
| Other Equity | 0 | 6 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Apr '19 | 1 |
| May '19 | 1 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 2 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 1 |
| Apr '21 | 1 |
| May '21 | 0 |
| Jun '21 | 0 |
| Jul '21 | 0 |
| Aug '21 | 1 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 2 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 1 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 0 |
| Aug '22 | 0 |
| Sep '22 | 1 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 1 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 1 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 1 |
| Aug '23 | 1 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 14 |
| Fintech | 4 |
| Data, Analytics & IT | 3 |
| Networks, Cloud & Communication | 2 |
| AI & Machine Learning | 2 |
| Space & Frontier Tech | 2 |
| Enterprise Software | 1 |
| Clean Energy & Sustainability | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 1 |
| $10M-$25M | 3 |
| $25M-$50M | 2 |
| $50M-$100M | 2 |
| $100M-$250M | 10 |
| $250M-$500M | 1 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 13 |
| Europe | 5 |
| China | 1 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Samsara BioCapital | 4 |
| Surveyor Capital | 4 |
| Alexandria Venture Investments | 3 |
| Casdin Capital | 3 |
| Leaps by Bayer | 3 |
| Mubadala Investment Company | 3 |
| RA Capital Management | 3 |
| Advantage Capital | 2 |
| Baillie Gifford | 2 |
| BVF Partners | 2 |
| Catalio Capital Management | 2 |
| Citi | 2 |
| Cormorant Asset Management | 2 |
| Data Collective | 2 |
| Deerfield Management | 2 |
| Epic Ventures | 2 |
| Felicis Ventures | 2 |
| Gray's Creek Capital Partners | 2 |
| HBM Healthcare Investments | 2 |
| Intel Capital | 2 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 0 | 0% |
| Participating | 19 | 100% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 0 | 0% |
| Co-led | 0 | 0% |
Lead dynamics requires at least one led deal in this range
Team
Founder & Partner
Founder